iQSTEL Inc (IQST) navigates financing with recent warrant adjustments

iQSTEL Inc. (IQST) has seen a flurry of financing activity recently, with the company disclosing warrant modifications and debt conversions that warrant a closer look. While press releases might focus on strategic moves, the SEC filings detail the mechanisms by which capital is raised and its potential impact on existing shareholders.

Specifically, a September 28, 2026, 8-K filing reveals an amendment to a previous convertible promissory note. This amendment includes a reduction in the exercise price of certain warrants from $2.00 to $1.00 per share and an extension of their expiration date to September 2028. Such adjustments, while potentially beneficial for the noteholder, increase the likelihood of warrant exercise at a lower price, leading to additional shares entering the market. This is a common mechanism for managing short-term liquidity, but it carries a direct implication for dilution risk.

Further, the same 8-K details the issuance of new warrants and the conversion of a portion of the note principal into common stock. The conversion rate for this debt into equity is set at $1.20 per share. When debt converts into shares, it adds to the outstanding share count. For a company with a market capitalization around $10 million and approximately 9.63 million shares outstanding, these conversions and warrant exercises represent a non-trivial percentage of the total float.

The company also filed a 10-Q/A on August 20, 2026, amending its quarterly report for the period ending June 30, 2026, following an initial 10-Q filing on August 18, 2026, and an NT 10-Q indicating a delay on August 14, 2026. While the amended filing itself doesn't inherently signal a problem, the sequence suggests internal adjustments or clarifications were necessary for the financial statements. Investors should always consider the context of such amendments.

In essence, iQSTEL is actively utilizing various financing instruments that involve equity-linked components. While these actions can provide necessary capital, the specifics of warrant exercise price reductions and debt-to-equity conversions are critical details for understanding the potential for future share count expansion. Investors should be clear on the mechanics of these agreements, as they directly influence their ownership percentage and the per-share value of their holdings.